

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 4.30303175 |
| 2 | valine metabolic process (GO:0006573) | 4.26582901 |
| 3 | lysine catabolic process (GO:0006554) | 4.22091807 |
| 4 | lysine metabolic process (GO:0006553) | 4.22091807 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06412209 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03951764 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.03951764 |
| 8 | amino-acid betaine transport (GO:0015838) | 3.96958040 |
| 9 | carnitine transport (GO:0015879) | 3.96958040 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 3.92914812 |
| 11 | carnitine transmembrane transport (GO:1902603) | 3.82007162 |
| 12 | 2-oxoglutarate metabolic process (GO:0006103) | 3.80016469 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 3.78598095 |
| 14 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.77098488 |
| 15 | tricarboxylic acid metabolic process (GO:0072350) | 3.73217653 |
| 16 | succinate metabolic process (GO:0006105) | 3.65141600 |
| 17 | quaternary ammonium group transport (GO:0015697) | 3.61617008 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.55931797 |
| 19 | negative T cell selection (GO:0043383) | 3.54997333 |
| 20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50419824 |
| 21 | aspartate family amino acid catabolic process (GO:0009068) | 3.46029336 |
| 22 | branched-chain amino acid metabolic process (GO:0009081) | 3.45289396 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 3.43294960 |
| 24 | activated T cell proliferation (GO:0050798) | 3.40927234 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.37499103 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35330151 |
| 27 | histone H3-K36 demethylation (GO:0070544) | 3.32582499 |
| 28 | branched-chain amino acid catabolic process (GO:0009083) | 3.28755235 |
| 29 | positive T cell selection (GO:0043368) | 3.27552256 |
| 30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.20980258 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 3.20068864 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 3.17642673 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.16200872 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15920861 |
| 35 | NADH metabolic process (GO:0006734) | 3.15851810 |
| 36 | cell communication by electrical coupling (GO:0010644) | 3.10031317 |
| 37 | regulation of fatty acid oxidation (GO:0046320) | 3.07355111 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07050962 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 3.05845060 |
| 40 | fatty acid oxidation (GO:0019395) | 3.05831999 |
| 41 | drug transmembrane transport (GO:0006855) | 3.05614709 |
| 42 | regulation of skeletal muscle contraction (GO:0014819) | 3.04255775 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.02773521 |
| 44 | lipid oxidation (GO:0034440) | 3.01594133 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.01362442 |
| 46 | biotin metabolic process (GO:0006768) | 3.01312268 |
| 47 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.98346331 |
| 48 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97572415 |
| 49 | sodium ion export (GO:0071436) | 2.94728427 |
| 50 | regulation of ARF protein signal transduction (GO:0032012) | 2.93407794 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91406615 |
| 52 | T cell selection (GO:0045058) | 2.91236102 |
| 53 | response to interleukin-15 (GO:0070672) | 2.89370933 |
| 54 | thymic T cell selection (GO:0045061) | 2.87036134 |
| 55 | cellular potassium ion homeostasis (GO:0030007) | 2.84915229 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.83321692 |
| 57 | carnitine metabolic process (GO:0009437) | 2.83242357 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 2.82883243 |
| 59 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82678498 |
| 60 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.81897193 |
| 61 | embryonic process involved in female pregnancy (GO:0060136) | 2.81846273 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.81588633 |
| 63 | regulation of Rap GTPase activity (GO:0032317) | 2.81564596 |
| 64 | germinal center formation (GO:0002467) | 2.77723547 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.76658204 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 2.75839944 |
| 67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.75558910 |
| 68 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.73126731 |
| 69 | organic cation transport (GO:0015695) | 2.72473127 |
| 70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.72208224 |
| 71 | intracellular lipid transport (GO:0032365) | 2.71075221 |
| 72 | glycine transport (GO:0015816) | 2.71021314 |
| 73 | cell communication involved in cardiac conduction (GO:0086065) | 2.70986707 |
| 74 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.70354171 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.69059463 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 2.68976348 |
| 77 | glycogen catabolic process (GO:0005980) | 2.68790638 |
| 78 | activation of protein kinase A activity (GO:0034199) | 2.68631058 |
| 79 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.68385807 |
| 80 | cellular extravasation (GO:0045123) | 2.68165750 |
| 81 | alpha-linolenic acid metabolic process (GO:0036109) | 2.67479912 |
| 82 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.66698436 |
| 83 | establishment of nucleus localization (GO:0040023) | 2.65318116 |
| 84 | alanine transport (GO:0032328) | 2.64728038 |
| 85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64692860 |
| 86 | proline transport (GO:0015824) | 2.63275150 |
| 87 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62824839 |
| 88 | positive regulation of Rap GTPase activity (GO:0032854) | 2.61731107 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 2.61482768 |
| 90 | relaxation of cardiac muscle (GO:0055119) | 2.60575133 |
| 91 | tolerance induction (GO:0002507) | 2.60361493 |
| 92 | plasma membrane repair (GO:0001778) | 2.59812652 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 2.58886290 |
| 94 | nerve growth factor signaling pathway (GO:0038180) | 2.58000044 |
| 95 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.57430873 |
| 96 | potassium ion import (GO:0010107) | 2.57084232 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56979518 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.56842067 |
| 99 | synaptic vesicle maturation (GO:0016188) | 2.55798095 |
| 100 | leukocyte aggregation (GO:0070486) | 2.55131126 |
| 101 | response to laminar fluid shear stress (GO:0034616) | 2.54803526 |
| 102 | histone lysine demethylation (GO:0070076) | 2.54614612 |
| 103 | regulation of cofactor metabolic process (GO:0051193) | 2.53872006 |
| 104 | regulation of coenzyme metabolic process (GO:0051196) | 2.53872006 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 2.53626277 |
| 106 | locomotory exploration behavior (GO:0035641) | 2.51487579 |
| 107 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.51306481 |
| 108 | glucan catabolic process (GO:0009251) | 2.49360613 |
| 109 | glyoxylate metabolic process (GO:0046487) | 2.49237909 |
| 110 | response to muramyl dipeptide (GO:0032495) | 2.49158368 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.48248042 |
| 112 | histone H3-K4 trimethylation (GO:0080182) | 2.47459640 |
| 113 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.46420515 |
| 114 | cardiac muscle contraction (GO:0060048) | 2.46263310 |
| 115 | positive regulation of glycolytic process (GO:0045821) | 2.46107599 |
| 116 | regulation of synapse structural plasticity (GO:0051823) | 2.44980975 |
| 117 | homocysteine metabolic process (GO:0050667) | 2.44434571 |
| 118 | cellular ketone body metabolic process (GO:0046950) | 2.43299911 |
| 119 | histone demethylation (GO:0016577) | 2.43042896 |
| 120 | potassium ion homeostasis (GO:0055075) | 2.42296720 |
| 121 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.40592580 |
| 122 | cellular sodium ion homeostasis (GO:0006883) | 2.40383838 |
| 123 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.40016864 |
| 124 | actin-myosin filament sliding (GO:0033275) | 2.39603094 |
| 125 | muscle filament sliding (GO:0030049) | 2.39603094 |
| 126 | cysteine metabolic process (GO:0006534) | 2.38808183 |
| 127 | L-phenylalanine catabolic process (GO:0006559) | 2.38263743 |
| 128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.38263743 |
| 129 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.36757490 |
| 130 | response to mercury ion (GO:0046689) | 2.35421705 |
| 131 | histone H3-K9 demethylation (GO:0033169) | 2.35196905 |
| 132 | regulation of tolerance induction (GO:0002643) | 2.35192577 |
| 133 | membrane depolarization during action potential (GO:0086010) | 2.34449331 |
| 134 | positive regulation of tolerance induction (GO:0002645) | 2.34241082 |
| 135 | phosphate ion transport (GO:0006817) | 2.34098351 |
| 136 | cellular polysaccharide catabolic process (GO:0044247) | 2.33927908 |
| 137 | regulation of membrane repolarization (GO:0060306) | 2.33502007 |
| 138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.33198750 |
| 139 | L-phenylalanine metabolic process (GO:0006558) | 2.33198750 |
| 140 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.32884913 |
| 141 | mannose metabolic process (GO:0006013) | 2.31787058 |
| 142 | kynurenine metabolic process (GO:0070189) | 2.30823531 |
| 143 | drug transport (GO:0015893) | 2.30415296 |
| 144 | creatine metabolic process (GO:0006600) | 2.30172905 |
| 145 | signal complex assembly (GO:0007172) | 2.30051189 |
| 146 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.29353074 |
| 147 | B cell homeostasis (GO:0001782) | 2.28831721 |
| 148 | cellular response to interleukin-15 (GO:0071350) | 2.28605807 |
| 149 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.28352909 |
| 150 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.27863371 |
| 151 | response to nerve growth factor (GO:1990089) | 2.27863371 |
| 152 | striated muscle contraction (GO:0006941) | 2.27723928 |
| 153 | substrate-dependent cell migration (GO:0006929) | 2.25936887 |
| 154 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.25175711 |
| 155 | negative regulation of myotube differentiation (GO:0010832) | 2.24983384 |
| 156 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.24438789 |
| 157 | regulation of histone H3-K27 methylation (GO:0061085) | 2.23610553 |
| 158 | cellular response to catecholamine stimulus (GO:0071870) | 2.22612720 |
| 159 | cellular response to monoamine stimulus (GO:0071868) | 2.22612720 |
| 160 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.20719150 |
| 161 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.20719150 |
| 162 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.20511388 |
| 163 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.19361338 |
| 164 | dosage compensation (GO:0007549) | 2.18864687 |
| 165 | T cell migration (GO:0072678) | 2.18551066 |
| 166 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.16300877 |
| 167 | pericardium development (GO:0060039) | 2.14482761 |
| 168 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.13407139 |
| 169 | detection of other organism (GO:0098543) | 2.11186867 |
| 170 | regulation of B cell differentiation (GO:0045577) | 2.10415229 |
| 171 | cellular response to ethanol (GO:0071361) | 2.09502744 |
| 172 | protein targeting to Golgi (GO:0000042) | 2.09003729 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.08431377 |
| 174 | cell migration in hindbrain (GO:0021535) | 2.08007840 |
| 175 | protein dealkylation (GO:0008214) | 2.07856491 |
| 176 | protein demethylation (GO:0006482) | 2.07856491 |
| 177 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.07509065 |
| 178 | regulation of necroptotic process (GO:0060544) | 2.06487274 |
| 179 | glycoprotein catabolic process (GO:0006516) | 2.04575264 |
| 180 | nucleus localization (GO:0051647) | 2.03338416 |
| 181 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.03131776 |
| 182 | establishment of protein localization to Golgi (GO:0072600) | 2.02809581 |
| 183 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.02638736 |
| 184 | response to fluid shear stress (GO:0034405) | 2.01763677 |
| 185 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.01382358 |
| 186 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.01382358 |
| 187 | modulation by symbiont of host immune response (GO:0052553) | 2.01382358 |
| 188 | positive regulation by symbiont of host defense response (GO:0052509) | 2.01382358 |
| 189 | modulation by symbiont of host defense response (GO:0052031) | 2.01382358 |
| 190 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.01382358 |
| 191 | regulation of ARF GTPase activity (GO:0032312) | 2.01365773 |
| 192 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.01288348 |
| 193 | cellular response to fluid shear stress (GO:0071498) | 2.01057320 |
| 194 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.01022109 |
| 195 | positive regulation of fibroblast migration (GO:0010763) | 2.00887432 |
| 196 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.98721417 |
| 197 | lipid translocation (GO:0034204) | 1.97936946 |
| 198 | phospholipid translocation (GO:0045332) | 1.97936946 |
| 199 | negative regulation of type 2 immune response (GO:0002829) | 1.97000236 |
| 200 | regulation of fibroblast apoptotic process (GO:2000269) | 1.96788404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.40524201 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74650060 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40854592 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.31630806 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64464068 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58684784 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.57160220 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52646431 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52030132 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43232621 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36440752 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32958567 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20946338 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.17686205 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14365108 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10072228 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06017934 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01989805 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.95111467 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.94420007 |
| 21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.87467814 |
| 22 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83226625 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83033606 |
| 24 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82216701 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82047381 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.69500759 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67774551 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66959276 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65990653 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64512292 |
| 31 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64423735 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63841991 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62750763 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61410395 |
| 35 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59804130 |
| 36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55648222 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54998466 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53965498 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.53380803 |
| 40 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.53192961 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51009184 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49054234 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49054234 |
| 44 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.46353227 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46234408 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45207259 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44583579 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44318575 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42357773 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42085847 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40689686 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39659295 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39621192 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37838580 |
| 55 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36509475 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35740596 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35667963 |
| 58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.35603893 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33418528 |
| 60 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32672614 |
| 61 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32672614 |
| 62 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32618132 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32559482 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31816838 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30726406 |
| 66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27826358 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27642778 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27590605 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.27229847 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25905026 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24161779 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23833360 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23829133 |
| 74 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.23776552 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23719004 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23168676 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21230051 |
| 78 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21008997 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.20258383 |
| 80 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18407269 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16801725 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16469109 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15226014 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15184055 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15105748 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14788656 |
| 87 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.13999351 |
| 88 | * MYB_26560356_Chip-Seq_TH1_Human | 1.13529698 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13423728 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13359989 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10092486 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08724731 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06476008 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06396296 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06214101 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05739441 |
| 97 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05156405 |
| 98 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.04502390 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04407096 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02515629 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02511810 |
| 102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01720280 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01643095 |
| 104 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01117900 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01083088 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00188800 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99391485 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99255062 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98653187 |
| 110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98142181 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97502222 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96688184 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96662880 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94773318 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94733111 |
| 116 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.94574631 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94556699 |
| 118 | AR_19668381_ChIP-Seq_PC3_Human | 0.93819481 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93389721 |
| 120 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92996348 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91662464 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90789111 |
| 123 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90383036 |
| 124 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90246716 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89962049 |
| 126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89624313 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89102107 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88810769 |
| 129 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88655047 |
| 130 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88290334 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88178451 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87895372 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87869017 |
| 134 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87636991 |
| 135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87514791 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86797691 |
| 137 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86788409 |
| 138 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86675619 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86489702 |
| 140 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85374949 |
| 141 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85191423 |
| 142 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.85035148 |
| 143 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84728123 |
| 144 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84635105 |
| 145 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83502495 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82881962 |
| 147 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.82795881 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82297050 |
| 149 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.81685814 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81630985 |
| 151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81569659 |
| 152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80802025 |
| 153 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80586240 |
| 154 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80026310 |
| 155 | MAF_26560356_Chip-Seq_TH2_Human | 0.79676630 |
| 156 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79170989 |
| 157 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.79016372 |
| 158 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.79016372 |
| 159 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78397157 |
| 160 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78397157 |
| 161 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77905958 |
| 162 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77402038 |
| 163 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76531281 |
| 164 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76215112 |
| 165 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75887570 |
| 166 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.75288078 |
| 167 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.73802056 |
| 168 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.72922986 |
| 169 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.71921648 |
| 170 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71344388 |
| 171 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71152455 |
| 172 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71040343 |
| 173 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70859027 |
| 174 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70828560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 3.43177050 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.19456971 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.13844798 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.05578170 |
| 5 | MP0004130_abnormal_muscle_cell | 3.02502068 |
| 6 | MP0000751_myopathy | 2.98727568 |
| 7 | MP0003436_decreased_susceptibility_to | 2.87506913 |
| 8 | MP0005365_abnormal_bile_salt | 2.81184276 |
| 9 | MP0005670_abnormal_white_adipose | 2.76005473 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.57700543 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.53999863 |
| 12 | MP0005360_urolithiasis | 2.53970512 |
| 13 | MP0003091_abnormal_cell_migration | 2.40432989 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.38518871 |
| 15 | MP0000749_muscle_degeneration | 2.38375803 |
| 16 | MP0004043_abnormal_pH_regulation | 2.34590894 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.34575643 |
| 18 | MP0003303_peritoneal_inflammation | 2.31561286 |
| 19 | MP0002822_catalepsy | 2.27709113 |
| 20 | MP0002009_preneoplasia | 2.27381347 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.24671474 |
| 22 | MP0003724_increased_susceptibility_to | 2.23552431 |
| 23 | MP0001800_abnormal_humoral_immune | 2.19169923 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.17643786 |
| 25 | MP0003279_aneurysm | 2.15165803 |
| 26 | MP0004510_myositis | 2.01759985 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.99459070 |
| 28 | MP0003828_pulmonary_edema | 1.99388557 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.93389863 |
| 30 | MP0008260_abnormal_autophagy | 1.91172608 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.91005978 |
| 32 | MP0005387_immune_system_phenotype | 1.90137679 |
| 33 | MP0001790_abnormal_immune_system | 1.90137679 |
| 34 | MP0005332_abnormal_amino_acid | 1.89403042 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.88356578 |
| 36 | MP0003252_abnormal_bile_duct | 1.86929680 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.86097592 |
| 38 | MP0003195_calcinosis | 1.85652151 |
| 39 | MP0005083_abnormal_biliary_tract | 1.78716956 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.78701045 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.72525555 |
| 42 | MP0000747_muscle_weakness | 1.72280711 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.71755150 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.69234281 |
| 45 | MP0005535_abnormal_body_temperature | 1.68660162 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.66457069 |
| 47 | MP0002269_muscular_atrophy | 1.65004831 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.62698130 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.61900431 |
| 50 | MP0005409_darkened_coat_color | 1.61313685 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.60320976 |
| 52 | MP0005330_cardiomyopathy | 1.58623321 |
| 53 | MP0002723_abnormal_immune_serum | 1.57917085 |
| 54 | MP0001819_abnormal_immune_cell | 1.56671184 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.56133043 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.53789762 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.53485546 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.51643012 |
| 59 | MP0003866_abnormal_defecation | 1.50718376 |
| 60 | MP0004233_abnormal_muscle_weight | 1.50591491 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 1.46007136 |
| 62 | MP0005451_abnormal_body_composition | 1.43629995 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.43527101 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43007741 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.42254019 |
| 66 | MP0005375_adipose_tissue_phenotype | 1.41573079 |
| 67 | MP0001851_eye_inflammation | 1.41436649 |
| 68 | MP0000685_abnormal_immune_system | 1.39925051 |
| 69 | MP0003283_abnormal_digestive_organ | 1.39563984 |
| 70 | MP0002933_joint_inflammation | 1.39236662 |
| 71 | MP0002419_abnormal_innate_immunity | 1.38657141 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.37188311 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 1.35018208 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.34759115 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 1.34322993 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.33913470 |
| 77 | MP0002106_abnormal_muscle_physiology | 1.33721247 |
| 78 | MP0002971_abnormal_brown_adipose | 1.32545417 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31267903 |
| 80 | MP0004947_skin_inflammation | 1.31075841 |
| 81 | MP0005671_abnormal_response_to | 1.31050304 |
| 82 | MP0003787_abnormal_imprinting | 1.30460427 |
| 83 | MP0000759_abnormal_skeletal_muscle | 1.28433500 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.27040615 |
| 85 | MP0000778_abnormal_nervous_system | 1.26761238 |
| 86 | MP0005025_abnormal_response_to | 1.26757692 |
| 87 | MP0002398_abnormal_bone_marrow | 1.26728101 |
| 88 | MP0002405_respiratory_system_inflammati | 1.26304053 |
| 89 | MP0004270_analgesia | 1.26141467 |
| 90 | MP0002998_abnormal_bone_remodeling | 1.25887193 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25251209 |
| 92 | MP0005076_abnormal_cell_differentiation | 1.24794618 |
| 93 | MP0002972_abnormal_cardiac_muscle | 1.23253242 |
| 94 | MP0000716_abnormal_immune_system | 1.22394656 |
| 95 | MP0000703_abnormal_thymus_morphology | 1.22060068 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.20675549 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.20231910 |
| 98 | MP0000230_abnormal_systemic_arterial | 1.16870461 |
| 99 | MP0010386_abnormal_urinary_bladder | 1.15391585 |
| 100 | MP0001756_abnormal_urination | 1.15320347 |
| 101 | MP0004085_abnormal_heartbeat | 1.14928836 |
| 102 | MP0005369_muscle_phenotype | 1.13413937 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 1.12850616 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 1.11904578 |
| 105 | MP0000003_abnormal_adipose_tissue | 1.10331849 |
| 106 | MP0003879_abnormal_hair_cell | 1.09884644 |
| 107 | MP0003137_abnormal_impulse_conducting | 1.09398871 |
| 108 | MP0003045_fibrosis | 1.08699422 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 1.08245515 |
| 110 | MP0005310_abnormal_salivary_gland | 1.07704503 |
| 111 | MP0002876_abnormal_thyroid_physiology | 1.07496820 |
| 112 | MP0003300_gastrointestinal_ulcer | 1.07475883 |
| 113 | MP0009384_cardiac_valve_regurgitation | 1.05089625 |
| 114 | MP0000689_abnormal_spleen_morphology | 1.02792378 |
| 115 | MP0004484_altered_response_of | 1.02355941 |
| 116 | MP0009745_abnormal_behavioral_response | 1.01175972 |
| 117 | MP0005334_abnormal_fat_pad | 0.99729747 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.99627792 |
| 119 | MP0008004_abnormal_stomach_pH | 0.98296131 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.97586236 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.97358609 |
| 122 | MP0009046_muscle_twitch | 0.96959056 |
| 123 | MP0002063_abnormal_learning/memory/cond | 0.96427251 |
| 124 | MP0003122_maternal_imprinting | 0.96287176 |
| 125 | MP0001873_stomach_inflammation | 0.95302651 |
| 126 | MP0002722_abnormal_immune_system | 0.94782006 |
| 127 | MP0000733_abnormal_muscle_development | 0.93351986 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.92481841 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.92011193 |
| 130 | MP0003868_abnormal_feces_composition | 0.91482933 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.91176699 |
| 132 | MP0005385_cardiovascular_system_phenoty | 0.91176699 |
| 133 | MP0003953_abnormal_hormone_level | 0.91009115 |
| 134 | MP0000750_abnormal_muscle_regeneration | 0.90670428 |
| 135 | MP0003191_abnormal_cellular_cholesterol | 0.90627026 |
| 136 | MP0000604_amyloidosis | 0.88613905 |
| 137 | MP0004858_abnormal_nervous_system | 0.88412941 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.88266847 |
| 139 | MP0003329_amyloid_beta_deposits | 0.88023472 |
| 140 | MP0005448_abnormal_energy_balance | 0.87637302 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.87376665 |
| 142 | MP0000462_abnormal_digestive_system | 0.87319744 |
| 143 | MP0005388_respiratory_system_phenotype | 0.86602077 |
| 144 | MP0002133_abnormal_respiratory_system | 0.86602077 |
| 145 | MP0002735_abnormal_chemical_nociception | 0.86461212 |
| 146 | MP0001849_ear_inflammation | 0.86180371 |
| 147 | MP0003633_abnormal_nervous_system | 0.86127444 |
| 148 | MP0000609_abnormal_liver_physiology | 0.84147456 |
| 149 | MP0002429_abnormal_blood_cell | 0.83717919 |
| 150 | MP0001348_abnormal_lacrimal_gland | 0.83704592 |
| 151 | MP0001968_abnormal_touch/_nociception | 0.83204393 |
| 152 | MP0003890_abnormal_embryonic-extraembry | 0.82805468 |
| 153 | MP0002925_abnormal_cardiovascular_devel | 0.81842743 |
| 154 | MP0003959_abnormal_lean_body | 0.81698224 |
| 155 | MP0008569_lethality_at_weaning | 0.81069400 |
| 156 | MP0009785_altered_susceptibility_to | 0.80628288 |
| 157 | MP0005381_digestive/alimentary_phenotyp | 0.80362296 |
| 158 | MP0004883_abnormal_blood_vessel | 0.80098807 |
| 159 | MP0002138_abnormal_hepatobiliary_system | 0.79880416 |
| 160 | MP0006138_congestive_heart_failure | 0.79875411 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.79687602 |
| 162 | MP0004272_abnormal_basement_membrane | 0.78992074 |
| 163 | MP0006035_abnormal_mitochondrial_morpho | 0.77855590 |
| 164 | MP0004147_increased_porphyrin_level | 0.77612018 |
| 165 | MP0002168_other_aberrant_phenotype | 0.77067293 |
| 166 | MP0002064_seizures | 0.76705166 |
| 167 | MP0001845_abnormal_inflammatory_respons | 0.76324221 |
| 168 | MP0001502_abnormal_circadian_rhythm | 0.76143865 |
| 169 | MP0002108_abnormal_muscle_morphology | 0.73130814 |
| 170 | MP0000569_abnormal_digit_pigmentation | 0.72142012 |
| 171 | MP0005275_abnormal_skin_tensile | 0.71755061 |
| 172 | MP0003448_altered_tumor_morphology | 0.71732188 |
| 173 | MP0001501_abnormal_sleep_pattern | 0.71566236 |
| 174 | MP0002928_abnormal_bile_duct | 0.71486032 |
| 175 | MP0005390_skeleton_phenotype | 0.71272220 |
| 176 | MP0002734_abnormal_mechanical_nocicepti | 0.71038002 |
| 177 | MP0000858_altered_metastatic_potential | 0.70020493 |
| 178 | MP0005621_abnormal_cell_physiology | 0.69548576 |
| 179 | MP0001663_abnormal_digestive_system | 0.69465635 |
| 180 | MP0001958_emphysema | 0.69162125 |
| 181 | MP0005464_abnormal_platelet_physiology | 0.69004941 |
| 182 | MP0002166_altered_tumor_susceptibility | 0.68634460 |
| 183 | MP0002396_abnormal_hematopoietic_system | 0.66753313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.05150035 |
| 2 | Myoglobinuria (HP:0002913) | 4.60137640 |
| 3 | Ketoacidosis (HP:0001993) | 4.16578844 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 3.92745611 |
| 5 | Ketosis (HP:0001946) | 3.85150033 |
| 6 | Gout (HP:0001997) | 3.69017467 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.61064598 |
| 8 | Hyperglycinuria (HP:0003108) | 3.57650575 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 3.57576499 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.41021544 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.32260036 |
| 12 | Sudden death (HP:0001699) | 3.29957948 |
| 13 | Arterial tortuosity (HP:0005116) | 3.11640279 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.00191962 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.99095380 |
| 16 | Bundle branch block (HP:0011710) | 2.98814566 |
| 17 | T lymphocytopenia (HP:0005403) | 2.97505350 |
| 18 | Mitral valve prolapse (HP:0001634) | 2.95965851 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.92094651 |
| 20 | Difficulty running (HP:0009046) | 2.90822225 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 2.88422051 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88422051 |
| 23 | Aortic dissection (HP:0002647) | 2.86633452 |
| 24 | Papilledema (HP:0001085) | 2.84664774 |
| 25 | Increased circulating renin level (HP:0000848) | 2.83098856 |
| 26 | Vascular tortuosity (HP:0004948) | 2.82980006 |
| 27 | Rhabdomyolysis (HP:0003201) | 2.80057575 |
| 28 | Aortic aneurysm (HP:0004942) | 2.79464188 |
| 29 | Cervical subluxation (HP:0003308) | 2.75523153 |
| 30 | Proximal tubulopathy (HP:0000114) | 2.74032070 |
| 31 | Peritonitis (HP:0002586) | 2.68068110 |
| 32 | Abnormality of the calf musculature (HP:0001430) | 2.67548925 |
| 33 | Hyperammonemia (HP:0001987) | 2.67436645 |
| 34 | Hyperuricemia (HP:0002149) | 2.67289549 |
| 35 | Increased purine levels (HP:0004368) | 2.67289549 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 2.67095234 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.63247365 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.63131421 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.60670636 |
| 40 | Prolonged QT interval (HP:0001657) | 2.57410731 |
| 41 | Facial diplegia (HP:0001349) | 2.53599925 |
| 42 | Hyperkalemia (HP:0002153) | 2.51013172 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.49038714 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.48817908 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.48351836 |
| 46 | Central scotoma (HP:0000603) | 2.48191595 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.47508668 |
| 48 | Muscle stiffness (HP:0003552) | 2.45975325 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.43779310 |
| 50 | Spondylolisthesis (HP:0003302) | 2.42812568 |
| 51 | Syringomyelia (HP:0003396) | 2.40305273 |
| 52 | Spinal cord lesions (HP:0100561) | 2.40305273 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.38014673 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.37916041 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37916041 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.37897618 |
| 57 | EMG: myopathic abnormalities (HP:0003458) | 2.37173278 |
| 58 | Muscle fiber splitting (HP:0003555) | 2.36398234 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.35308688 |
| 60 | Atrial fibrillation (HP:0005110) | 2.34272638 |
| 61 | Heart block (HP:0012722) | 2.33743866 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.32756495 |
| 63 | Hematochezia (HP:0002573) | 2.30890662 |
| 64 | Syncope (HP:0001279) | 2.29039946 |
| 65 | Hyperglycinemia (HP:0002154) | 2.28524824 |
| 66 | Increased connective tissue (HP:0009025) | 2.23949671 |
| 67 | Protrusio acetabuli (HP:0003179) | 2.23586319 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.21629726 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.21629726 |
| 70 | Broad face (HP:0000283) | 2.19322959 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.19293357 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19239921 |
| 73 | Dislocated radial head (HP:0003083) | 2.17919353 |
| 74 | Atrophic scars (HP:0001075) | 2.17240903 |
| 75 | Overgrowth (HP:0001548) | 2.16739016 |
| 76 | Distal arthrogryposis (HP:0005684) | 2.15773549 |
| 77 | Nemaline bodies (HP:0003798) | 2.15523255 |
| 78 | Recurrent bacterial skin infections (HP:0005406) | 2.14211497 |
| 79 | Gingivitis (HP:0000230) | 2.14149893 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.14070479 |
| 81 | Atrioventricular block (HP:0001678) | 2.14034630 |
| 82 | Vitreoretinal degeneration (HP:0000655) | 2.13484569 |
| 83 | Myopathic facies (HP:0002058) | 2.13425399 |
| 84 | Palpitations (HP:0001962) | 2.13003242 |
| 85 | Primary atrial arrhythmia (HP:0001692) | 2.12692876 |
| 86 | Narrow palate (HP:0000189) | 2.11032574 |
| 87 | Ventricular arrhythmia (HP:0004308) | 2.10590171 |
| 88 | Myotonia (HP:0002486) | 2.10523714 |
| 89 | Disproportionate tall stature (HP:0001519) | 2.10436239 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10065875 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09078522 |
| 92 | Abnormal EKG (HP:0003115) | 2.08405375 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08059316 |
| 94 | Abnormality of potassium homeostasis (HP:0011042) | 2.06487554 |
| 95 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05104208 |
| 96 | Subaortic stenosis (HP:0001682) | 2.05104208 |
| 97 | Recurrent fungal infections (HP:0002841) | 2.03545658 |
| 98 | Subacute progressive viral hepatitis (HP:0006572) | 2.01434142 |
| 99 | Ventricular tachycardia (HP:0004756) | 2.01409322 |
| 100 | Aneurysm (HP:0002617) | 2.00902895 |
| 101 | Gastrointestinal infarctions (HP:0005244) | 2.00703682 |
| 102 | Thin bony cortex (HP:0002753) | 1.99450266 |
| 103 | Supraventricular tachycardia (HP:0004755) | 1.97486436 |
| 104 | Dysmetric saccades (HP:0000641) | 1.97140060 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96780044 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96780044 |
| 107 | Hypoalphalipoproteinemia (HP:0003233) | 1.96612877 |
| 108 | Recurrent abscess formation (HP:0002722) | 1.96383703 |
| 109 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96367912 |
| 110 | Abnormality of the radial head (HP:0003995) | 1.95598792 |
| 111 | Heterotopia (HP:0002282) | 1.94650127 |
| 112 | Metabolic acidosis (HP:0001942) | 1.93974622 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 1.92947442 |
| 114 | Neonatal onset (HP:0003623) | 1.92915541 |
| 115 | Difficulty climbing stairs (HP:0003551) | 1.92853432 |
| 116 | Abnormality of macrophages (HP:0004311) | 1.92763164 |
| 117 | Absent frontal sinuses (HP:0002688) | 1.92301555 |
| 118 | Supraventricular arrhythmia (HP:0005115) | 1.92279241 |
| 119 | Impaired social interactions (HP:0000735) | 1.92169842 |
| 120 | Abnormal social behavior (HP:0012433) | 1.92169842 |
| 121 | Focal motor seizures (HP:0011153) | 1.91724147 |
| 122 | Ulnar deviation of the wrist (HP:0003049) | 1.91402530 |
| 123 | Myositis (HP:0100614) | 1.91293377 |
| 124 | Broad palm (HP:0001169) | 1.90227829 |
| 125 | Broad ribs (HP:0000885) | 1.89722125 |
| 126 | Frequent falls (HP:0002359) | 1.88694901 |
| 127 | Postural instability (HP:0002172) | 1.88158993 |
| 128 | Xanthomatosis (HP:0000991) | 1.87269184 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86665333 |
| 130 | Pustule (HP:0200039) | 1.86324217 |
| 131 | Visual hallucinations (HP:0002367) | 1.85377991 |
| 132 | Thoracolumbar scoliosis (HP:0002944) | 1.85350780 |
| 133 | Hypokalemia (HP:0002900) | 1.84994296 |
| 134 | Right ventricular cardiomyopathy (HP:0011663) | 1.83876234 |
| 135 | Dilated cardiomyopathy (HP:0001644) | 1.83838641 |
| 136 | Genu recurvatum (HP:0002816) | 1.83555636 |
| 137 | Bicuspid aortic valve (HP:0001647) | 1.81730863 |
| 138 | Lipoatrophy (HP:0100578) | 1.81149943 |
| 139 | Abnormality of renal excretion (HP:0011036) | 1.80941745 |
| 140 | Long toe (HP:0010511) | 1.80339846 |
| 141 | Poor eye contact (HP:0000817) | 1.80334948 |
| 142 | Hypoglycemic seizures (HP:0002173) | 1.79836482 |
| 143 | Abnormal urine output (HP:0012590) | 1.79751315 |
| 144 | Cellulitis (HP:0100658) | 1.79660860 |
| 145 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.78741415 |
| 146 | Lymphangioma (HP:0100764) | 1.77780260 |
| 147 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77503393 |
| 148 | Hyperaldosteronism (HP:0000859) | 1.75737476 |
| 149 | Late onset (HP:0003584) | 1.75726741 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.74160278 |
| 151 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74113972 |
| 152 | Generalized muscle weakness (HP:0003324) | 1.73342355 |
| 153 | Premature rupture of membranes (HP:0001788) | 1.73038252 |
| 154 | Oligomenorrhea (HP:0000876) | 1.72889070 |
| 155 | Slow saccadic eye movements (HP:0000514) | 1.72411852 |
| 156 | Mitral regurgitation (HP:0001653) | 1.71930976 |
| 157 | Joint laxity (HP:0001388) | 1.70408850 |
| 158 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.70175674 |
| 159 | Stomatitis (HP:0010280) | 1.68345752 |
| 160 | Metaphyseal cupping (HP:0003021) | 1.67720849 |
| 161 | Optic neuritis (HP:0100653) | 1.66571670 |
| 162 | Retrobulbar optic neuritis (HP:0100654) | 1.66571670 |
| 163 | Meningitis (HP:0001287) | 1.65429585 |
| 164 | Orchitis (HP:0100796) | 1.64077808 |
| 165 | Pulmonary infiltrates (HP:0002113) | 1.63839313 |
| 166 | Abnormality of the peritoneum (HP:0002585) | 1.63573824 |
| 167 | Abnormality of the humeroradial joint (HP:0100744) | 1.63215079 |
| 168 | Neonatal hypoglycemia (HP:0001998) | 1.63045755 |
| 169 | Gastrointestinal stroma tumor (HP:0100723) | 1.62139987 |
| 170 | Supranuclear gaze palsy (HP:0000605) | 1.61903822 |
| 171 | Excessive salivation (HP:0003781) | 1.61854207 |
| 172 | Long eyelashes (HP:0000527) | 1.60911658 |
| 173 | Chest pain (HP:0100749) | 1.60382913 |
| 174 | Papilloma (HP:0012740) | 1.59257129 |
| 175 | Verrucae (HP:0200043) | 1.59257129 |
| 176 | Thickened calvaria (HP:0002684) | 1.58941547 |
| 177 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.58892356 |
| 178 | Lower limb muscle weakness (HP:0007340) | 1.58566303 |
| 179 | Persistence of primary teeth (HP:0006335) | 1.58427993 |
| 180 | Leukocytosis (HP:0001974) | 1.57078393 |
| 181 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.56921406 |
| 182 | Colitis (HP:0002583) | 1.56767984 |
| 183 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.56222839 |
| 184 | Vasculitis (HP:0002633) | 1.55214067 |
| 185 | Truncal obesity (HP:0001956) | 1.54983046 |
| 186 | Inflammation of the large intestine (HP:0002037) | 1.54725163 |
| 187 | Mild short stature (HP:0003502) | 1.53613099 |
| 188 | Vertebral arch anomaly (HP:0008438) | 1.53579173 |
| 189 | Recurrent bronchitis (HP:0002837) | 1.52925230 |
| 190 | Lymphopenia (HP:0001888) | 1.52530035 |
| 191 | Hip dysplasia (HP:0001385) | 1.52519963 |
| 192 | Flat acetabular roof (HP:0003180) | 1.52359549 |
| 193 | Abnormality of skull ossification (HP:0002703) | 1.50813126 |
| 194 | Recurrent viral infections (HP:0004429) | 1.50500625 |
| 195 | Genetic anticipation (HP:0003743) | 1.50469927 |
| 196 | Gastrointestinal inflammation (HP:0004386) | 1.50287830 |
| 197 | Hypoplastic nipples (HP:0002557) | 1.50091498 |
| 198 | Round face (HP:0000311) | 1.49431798 |
| 199 | Bladder neoplasm (HP:0009725) | 1.48943882 |
| 200 | Bladder carcinoma (HP:0002862) | 1.48943882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.21555233 |
| 2 | PDK3 | 3.10823140 |
| 3 | PDK4 | 3.10823140 |
| 4 | TRIB3 | 2.87608307 |
| 5 | PHKG2 | 2.52177218 |
| 6 | PHKG1 | 2.52177218 |
| 7 | OBSCN | 2.47440610 |
| 8 | PINK1 | 2.45846192 |
| 9 | TTN | 2.41951425 |
| 10 | PKN2 | 2.38745716 |
| 11 | MAP3K10 | 2.21815550 |
| 12 | PRPF4B | 2.21799772 |
| 13 | PRKD3 | 2.17133864 |
| 14 | MAP4K1 | 2.16067729 |
| 15 | NTRK3 | 2.07805770 |
| 16 | INSRR | 2.06837462 |
| 17 | WNK4 | 2.05716257 |
| 18 | LMTK2 | 1.99389646 |
| 19 | PDK2 | 1.93118828 |
| 20 | RIPK1 | 1.89815230 |
| 21 | TYK2 | 1.79509130 |
| 22 | SIK1 | 1.72203266 |
| 23 | DAPK2 | 1.70949681 |
| 24 | EPHB1 | 1.70450634 |
| 25 | NEK1 | 1.70120480 |
| 26 | STK38 | 1.68720722 |
| 27 | TYRO3 | 1.66337124 |
| 28 | ERN1 | 1.62693020 |
| 29 | NLK | 1.56832221 |
| 30 | CDK12 | 1.56784781 |
| 31 | CAMKK1 | 1.55857983 |
| 32 | BLK | 1.54750695 |
| 33 | MAP3K7 | 1.52293160 |
| 34 | BRD4 | 1.46513593 |
| 35 | ZAP70 | 1.44493101 |
| 36 | TXK | 1.41349418 |
| 37 | EPHA4 | 1.40145465 |
| 38 | RIPK4 | 1.36449001 |
| 39 | MAP2K4 | 1.35201628 |
| 40 | MAP3K14 | 1.35027700 |
| 41 | FES | 1.34966461 |
| 42 | JAK3 | 1.34454047 |
| 43 | MAP3K4 | 1.28852156 |
| 44 | ITK | 1.28617497 |
| 45 | DYRK1B | 1.26201838 |
| 46 | PIK3CG | 1.25500945 |
| 47 | SIK3 | 1.23422465 |
| 48 | CAMK1G | 1.22891157 |
| 49 | MAP3K9 | 1.20266078 |
| 50 | BTK | 1.20001925 |
| 51 | KSR1 | 1.18092079 |
| 52 | CSK | 1.15634081 |
| 53 | PASK | 1.13422739 |
| 54 | PDGFRB | 1.11779111 |
| 55 | MARK1 | 1.10233659 |
| 56 | SGK3 | 1.07378508 |
| 57 | CASK | 1.07228365 |
| 58 | CAMK1D | 1.05567779 |
| 59 | DMPK | 1.02563069 |
| 60 | GRK6 | 1.01820888 |
| 61 | IRAK4 | 1.01641530 |
| 62 | TIE1 | 1.00030352 |
| 63 | PRKCH | 0.99796618 |
| 64 | WNK3 | 0.97628440 |
| 65 | PDK1 | 0.97391150 |
| 66 | PAK6 | 0.97009546 |
| 67 | FGR | 0.94876356 |
| 68 | KSR2 | 0.94671211 |
| 69 | HCK | 0.93296386 |
| 70 | SYK | 0.93116490 |
| 71 | PRKAA1 | 0.91794882 |
| 72 | MYLK | 0.90781088 |
| 73 | JAK1 | 0.90402584 |
| 74 | PDPK1 | 0.89325008 |
| 75 | MINK1 | 0.88583031 |
| 76 | LCK | 0.88173298 |
| 77 | PRKD2 | 0.87839464 |
| 78 | RET | 0.87782911 |
| 79 | CAMKK2 | 0.84405316 |
| 80 | PDGFRA | 0.84251202 |
| 81 | AKT3 | 0.84201422 |
| 82 | SGK2 | 0.83528064 |
| 83 | MAP2K7 | 0.82213281 |
| 84 | MAPK7 | 0.81622140 |
| 85 | MAP3K13 | 0.81416753 |
| 86 | WNK1 | 0.80866254 |
| 87 | IKBKE | 0.80314322 |
| 88 | FLT3 | 0.80080301 |
| 89 | TAOK1 | 0.79342473 |
| 90 | PTK6 | 0.78984951 |
| 91 | FGFR2 | 0.77725192 |
| 92 | MAP3K6 | 0.77607368 |
| 93 | SCYL2 | 0.77268151 |
| 94 | PRKAA2 | 0.76609478 |
| 95 | TAOK3 | 0.75815075 |
| 96 | YES1 | 0.75105035 |
| 97 | STK11 | 0.74982330 |
| 98 | CAMK1 | 0.74813213 |
| 99 | SIK2 | 0.74535133 |
| 100 | TNK2 | 0.74298999 |
| 101 | UHMK1 | 0.73436008 |
| 102 | IRAK3 | 0.73174803 |
| 103 | MAPK12 | 0.73081369 |
| 104 | EPHB2 | 0.72259484 |
| 105 | MAP3K2 | 0.71870618 |
| 106 | FRK | 0.71572179 |
| 107 | NTRK1 | 0.71470973 |
| 108 | FGFR4 | 0.70914246 |
| 109 | PIK3CA | 0.70527497 |
| 110 | SGK223 | 0.69853995 |
| 111 | SGK494 | 0.69853995 |
| 112 | MAP3K1 | 0.67973917 |
| 113 | CDK6 | 0.67689217 |
| 114 | DYRK1A | 0.66902886 |
| 115 | LYN | 0.64390330 |
| 116 | CDC42BPA | 0.64360810 |
| 117 | PTK2B | 0.64005273 |
| 118 | OXSR1 | 0.63909723 |
| 119 | FYN | 0.62860207 |
| 120 | JAK2 | 0.61662618 |
| 121 | TEC | 0.61390420 |
| 122 | SGK1 | 0.58208981 |
| 123 | MAP2K6 | 0.57766493 |
| 124 | FER | 0.57448490 |
| 125 | CDK5 | 0.57124138 |
| 126 | ICK | 0.56480768 |
| 127 | CSF1R | 0.56430547 |
| 128 | HIPK2 | 0.56107836 |
| 129 | CAMK4 | 0.53229063 |
| 130 | EPHA3 | 0.52725676 |
| 131 | FGFR3 | 0.52563740 |
| 132 | PAK3 | 0.51836713 |
| 133 | TGFBR2 | 0.50053313 |
| 134 | MAPKAPK3 | 0.50011152 |
| 135 | MELK | 0.49401817 |
| 136 | MARK3 | 0.48870879 |
| 137 | MAP2K1 | 0.48594930 |
| 138 | STK39 | 0.47799523 |
| 139 | MAP2K3 | 0.47170346 |
| 140 | LATS1 | 0.45248086 |
| 141 | NTRK2 | 0.43194113 |
| 142 | MAPK11 | 0.42692324 |
| 143 | PRKD1 | 0.42532619 |
| 144 | RPS6KA2 | 0.41176013 |
| 145 | PRKACG | 0.40947426 |
| 146 | MUSK | 0.40622098 |
| 147 | PRKCG | 0.39881671 |
| 148 | MARK2 | 0.39352054 |
| 149 | RPS6KA3 | 0.39006067 |
| 150 | PRKCZ | 0.38975065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.23083507 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.04946975 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69535128 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.55827520 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51186686 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41307933 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10705511 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.08038352 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02270391 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92205203 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82326198 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75288822 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69200223 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68293399 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66537956 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61003890 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54197667 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53464787 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52366577 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45656983 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41934420 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40850064 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38488143 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38091184 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35898791 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35390076 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33027299 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32730402 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31702624 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29019466 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28982383 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28803488 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.27795260 |
| 34 | Colorectal cancer_Homo sapiens_hsa05210 | 1.23746964 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.22685581 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21970701 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.21217513 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20831703 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20006151 |
| 40 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.19940791 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19637257 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.19586660 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18868278 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17647984 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16823244 |
| 46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15901223 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.14909447 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 1.13822671 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13699097 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.13057513 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12834315 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12722339 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10435743 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09576344 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09469004 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09307281 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07936679 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07656373 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06880690 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06743676 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06171923 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05816584 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05690498 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05656874 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05420973 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05169359 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04700836 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04524865 |
| 69 | Measles_Homo sapiens_hsa05162 | 1.04116043 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03972955 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 1.03494181 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02955944 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00849573 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 1.00097510 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99097637 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.98979327 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98915984 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.98878980 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98205846 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97986764 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97900653 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97554428 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.97440406 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96382017 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96037563 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.95477576 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95259017 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.95251026 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94268862 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.93563610 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.93412561 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93309588 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.92938151 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.90481283 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90138014 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89557759 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88685715 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.88493519 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.87645155 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87315654 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86621514 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85288040 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84860720 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84017634 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83431258 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83162548 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.82946918 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82711977 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81520335 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80724701 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.80139919 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80138598 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79527663 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.78303255 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78127774 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78111537 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77874500 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77426616 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77066981 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76864980 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76660642 |
| 122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76468499 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76057122 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76032742 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74127488 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73852319 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73743135 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.72747596 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72133039 |
| 130 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71789983 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.70394317 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70038640 |
| 133 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68447180 |
| 134 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67182191 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66071171 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.65995879 |
| 137 | Malaria_Homo sapiens_hsa05144 | 0.65411840 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64924323 |
| 139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64864350 |
| 140 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64802950 |
| 141 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64663391 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.64555770 |
| 143 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63721854 |
| 144 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63095582 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62748281 |
| 146 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62632358 |
| 147 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61799128 |
| 148 | Gap junction_Homo sapiens_hsa04540 | 0.61763159 |
| 149 | Phagosome_Homo sapiens_hsa04145 | 0.61458277 |
| 150 | Melanogenesis_Homo sapiens_hsa04916 | 0.60741953 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.60626673 |
| 152 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60164023 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59378341 |
| 154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58033459 |
| 155 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57986198 |
| 156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56917710 |
| 157 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56358526 |
| 158 | Nicotine addiction_Homo sapiens_hsa05033 | 0.54886361 |
| 159 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53581547 |
| 160 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53034593 |
| 161 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51082396 |
| 162 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49700186 |
| 163 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49113134 |
| 164 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48981585 |
| 165 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48933016 |
| 166 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48400742 |
| 167 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47415495 |
| 168 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47317132 |
| 169 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46271314 |
| 170 | Taste transduction_Homo sapiens_hsa04742 | 0.43711103 |
| 171 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41334801 |
| 172 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41118199 |
| 173 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39746801 |
| 174 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38747638 |
| 175 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38480698 |
| 176 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35019517 |
| 177 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33959958 |
| 178 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33782592 |
| 179 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31119267 |
| 180 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31060030 |

